ORIGINAL ARTICLE  CARDIAC SECTION 

The Journal of Cardiovascular Surgery 2019 June;60(3):388-95

DOI: 10.23736/S0021-9509.18.10697-5

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Mid- and long-term prognosis of off- vs. on-pump coronary artery bypass graft in patients with multisite artery disease

Louis LE BIVIC ^{1, 2, 3}, Julien MAGNE ^{1, 2, 3}, Jean-David BLOSSIER ^{1, 2, 3}, Alessandro PICCARDO ^{1, 2, 3}, Hélène WOJTYNA ^{1, 2, 3}, Philippe LACROIX ^{1, 2, 3}, Dania MOHTY ^{1, 2, 3}, Elisabeth CORNU ^{1, 2, 3}, Alexandre LE GUYADER ^{1, 2, 3}, Victor ABOYANS ^{1, 2, 3} ✉

¹ CHU Limoges, Service of Cardiology, Dupuytren Hospital, Limoges, France; ² INSERM 1094, Faculty of Medicine, Limoges, France; ³ CHU Limoges, Service of Thoracic and Cardiovascular Surgery, Dupuytren Hospital, Limoges, France

BACKGROUND: Among patients with coronary artery disease (CAD), around 25% have multisite artery disease (MSAD). Patients with CAD and MSAD are at higher risk of peri-operative and long-term cardiovascular events. Whether off-pump coronary bypass grafting (CABG) can improve their prognosis is unknown. We aimed to assess the benefits of off- vs. on-pump cardiac surgery in patients undergoing CABG, according to coexistence of extra-cardiac artery disease.
METHODS: Between April 1998 and September 2008, 1221 patients undergoing CABG without any other intervention were enrolled. Overall death and major cardiovascular events were recorded at 1-month and during long-term follow-up. A propensity score (PS), derived from all relevant variables (P<0.25) associated with on-pump as compared to off-pump CABG, and representing the likelihood for each individual patient to receive off-pump CABG, was calculated.
RESULTS: MSAD was observed in 279 patients (23%). Off-pump CABG was performed in 208 (17%) patients. The median follow-up was 7.6 years. The 10-year mortality was significantly lower in off- vs. on-pump CABG group (74±4% vs. 68±2%, P=0.024). In patients with MSAD, there was a trend for better survival for off- vs. on-pump CABG (63±8% vs. 50±4%, P=0.078). After adjustment for PS, we found no further difference between on- and off-pump CABG both in the whole cohort (HR=1.30, P=0.10), as well as in MSAD patients (HR=1.51, P=0.14).
CONCLUSIONS: Patients with MSAD receiving CABG are at worst prognostic than those with isolated CAD. In these patients, we found no significant difference in the long-term mortality and cardiovascular events between on- and off-pump CABG.

KEY WORDS: Atherosclerosis; Coronary artery disease; Coronary artery bypass